Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Molecular diagnostics company CareDx nets $8.4mm in FOPO

Executive Summary

CareDx Inc. (molecular diagnostics for transplant patients) netted $8.4mm in a follow-on public offering of 2.25mm common shares at $4. Earlier in the year the company raised additional funds in a private placement to support its acquisition of Allenex AB. The company will use the proceeds to support the continued development of AlloSure for a clinical utility trial and commercialization.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

Advertisement
UsernamePublicRestriction

Register